Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial performance, with significant net income growth and increased revenues in key segments. The effective tax rate and operational efficiencies further enhance the positive outlook. Despite some uncertainties in military deployments, the company is strategically focusing on growth and investments, with optimistic guidance for future initiatives. The Q&A reveals a cautious but positive sentiment towards overcoming challenges, particularly in military enrollments. Overall, the company's strong financial health and strategic initiatives are likely to positively influence the stock price.
Total Revenue $174.7 million, a 6.2% increase year-over-year. Excluding $3.7 million of graduate school USA revenue from the prior year, revenue grew 8.7%, reflecting underlying business strength.
Adjusted EBITDA $29.2 million, a 37.5% increase year-over-year. The prior year included $2.2 million of graduate school losses, and the current period benefited from a one-time favorable tax treatment of stock appreciation.
Net Income per Diluted Share $0.94, a 129% increase year-over-year. This reflects operational improvements and a favorable 8% effective tax rate driven by higher-than-expected tax deductions from stock price increases.
Health+ Revenue $85.4 million, an 11% increase year-over-year. Growth was driven by 8% enrollment growth and a modest price increase, demonstrating strong demand for nursing education.
Military+ Revenue $89.4 million, a 6.5% increase year-over-year. Growth was supported by a 4% increase in registrations, with high teens growth in military families and veterans' registrations.
Military+ Adjusted EBITDA Margin Approximately 36%, reflecting cost discipline and operational efficiency improvements completed in 2025.
Cash, Cash Equivalents, and Restricted Cash $221 million as of March 31, 2026, a 25% increase from $176.5 million at December 31, 2025, driven by strong cash generation.
Total Debt $90 million as of March 31, 2026, reduced from $96.4 million at December 31, 2025, due to refinancing that also lowered borrowing rates by 375 basis points.
Health+ revenue growth: Health+ revenue grew 11%, driven by 8% enrollment growth and a modest price increase. This reflects strong demand for pre-licensure nursing education.
Military+ revenue growth: Military+ revenue grew 6.5%, supported by 4% registration growth and high teens registration growth for military families and veterans.
Campus expansion: New Rasmussen Orlando campus is operational and enrolling students. Hondros College of Nursing Cincinnati campus relocation and new Detroit campus are planned for completion in late 2026 and early 2027, respectively.
Military+ registration growth: Growth in Army registrations offset by a slowdown in Navy, Air Force, and Marine registrations due to Middle East deployments. Veterans & Family segments continue to show high teens registration growth.
Adjusted EBITDA improvement: Adjusted EBITDA grew 37.5% year-over-year to $29.2 million, reflecting cost discipline and operational leverage.
Net income growth: Net income per diluted share increased by 129% year-over-year to $0.94, driven by operational improvements and favorable tax treatment.
Segment restructuring: APEI restructured into two segments, Military+ and Health+, following the merger of its institutions. This simplifies operations and aligns with strategic goals.
Institutional combination: Approval received from the Higher Learning Commission to consolidate APUS, Rasmussen, and Hondros College of Nursing into a single accredited institution, targeting completion by Q3 2026.
Government Shutdowns and Policy Changes: Potential impacts from government shutdowns or changes in federal or state government policies, laws, practices, and actions could affect revenue or the timing of receivables.
Military+ Enrollment Challenges: Temporary suspension of Department of Homeland Security funding during a government shutdown affected Coast Guard registrations, delaying 1%-2% of total registrations. Additionally, deployments related to the war in the Middle East have caused a slowdown in Navy, Air Force, and Marine registrations.
Health+ Campus Relocation Risks: The relocation of the Hondros College of Nursing Cincinnati campus and the opening of the new Detroit campus carry risks related to execution and potential delays.
Marketing Spend Shifts: Shifts in marketing spend between quarters could impact adjusted EBITDA margins and financial performance in the short term.
Active Duty Deployment Impact: Deployments and combat readiness for Navy, Air Force, and Marine service members due to the Middle East conflict have led to an uptick in leave of absence requests, delaying educational progression.
Full Year 2026 Guidance: APEI raised its full-year 2026 guidance for revenue, adjusted EBITDA, and diluted EPS. Revenue is now expected to be between $686 million and $696 million, adjusted EBITDA between $93 million and $102 million, and diluted EPS between $2.33 and $2.68.
Second Quarter 2026 Guidance: Revenue is projected to be between $170 million and $172 million, net income available to common stockholders between $6.5 million and $7.5 million, adjusted EBITDA between $16.5 million and $18 million, and diluted EPS between $0.34 and $0.39.
Health+ Segment Growth: Health+ revenue grew 11% in Q1 2026, driven by 8% enrollment growth and a modest price increase. Enrollment growth of 7.1% is expected in Q2 2026. Expansion plans include a new Rasmussen Orlando campus and relocation of the Hondros College of Nursing Cincinnati campus in late 2026, with a new Detroit campus expected to enroll students in Q1 2027.
Military+ Segment Growth: Military+ achieved 4% registration growth in Q1 2026, with high teens growth for military families and veterans. Adjusted EBITDA margin was approximately 36%. Recovery of Coast Guard registrations is expected in Q3 2026 and beyond. Army registrations are growing, but Navy, Air Force, and Marine registrations face short-term headwinds due to Middle East deployments.
Long-Term Growth Framework: APEI targets organic revenue of $890 million to $925 million by 2029, representing an 8%-9% revenue CAGR, with adjusted EBITDA margins of 20%-21%. Strategic investments in new campuses and potential acquisitions could push revenue to $1 billion by 2029.
Share Repurchase Program: In March, the Board authorized a $50 million share repurchase program. During the first quarter, approximately 17,840 shares of common stock were repurchased for a total consideration of approximately $1 million. The program is primarily aimed at offsetting dilution from share-based compensation, with flexibility for opportunistic repurchases subject to market conditions and a disciplined approach to capital allocation.
The earnings call highlights strong financial performance, with significant net income growth and increased revenues in key segments. The effective tax rate and operational efficiencies further enhance the positive outlook. Despite some uncertainties in military deployments, the company is strategically focusing on growth and investments, with optimistic guidance for future initiatives. The Q&A reveals a cautious but positive sentiment towards overcoming challenges, particularly in military enrollments. Overall, the company's strong financial health and strategic initiatives are likely to positively influence the stock price.
The earnings call highlights a 5% revenue increase and a 20% net income growth, indicating strong financial performance. Improved operating margin and cash flow further support a positive outlook. Despite forward-looking statements being subject to risks, the overall financial health and strategic focus on core growth areas like military and healthcare suggest optimism. The absence of negative Q&A feedback reinforces the positive sentiment, predicting a 2% to 8% stock price increase.
The earnings call revealed mixed sentiments. Strong enrollment growth and positive guidance for adjusted EBITDA and free cash flow are countered by a projected net loss in Q3 and concerns about APUS registration declines. Cost-saving measures and a lack of specific details on capacity growth and future profit impacts add uncertainty. Overall, the neutral sentiment reflects balanced positive and negative factors, with no clear catalyst for significant stock movement.
The earnings call shows strong financial metrics, such as increased EBITDA, cash flow, and unrestricted cash. Despite some negative aspects like reduced Graduate School revenue and unclear military funding distribution, the overall sentiment is positive. The consolidation plan, breakeven status of Rasmussen and Hondros, and increased guidance for EBITDA and net income further support this view. The Q&A reveals potential growth through consolidation and military enrollments, although some management responses lacked clarity. Overall, the positive aspects outweigh the negatives, suggesting a likely stock price increase.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.